Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano chitosan-doxepin mucoadhesive dressing for oral mucositis
IRCT20110428006322N4Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of doxepin and chitosan in stomatitis (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Lesion size, Pain and disability and 3 more. Started Oct 2021; status: completed.
02
Drugs
doxepinchitosan
03
Conditions
stomatitis
Beyond the preview
Go deeper on IRCT20110428006322N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110428006322N4.